Biodesix Inc. Announces 1-for-20 Reverse Stock Split and Bylaw Amendments
Biodesix Inc. has announced amendments to its bylaws, including a one-for-twenty reverse stock split of its common stock, effective September 15, 2025. The company's board had previously received authorization from stockholders to implement a reverse stock split within a specified range, and they approved the final ratio. Additionally, Biodesix filed a Certificate of Elimination for its Series A Non-Voting Convertible Preferred Stock, effective September 12, 2025, eliminating all provisions related to this series of preferred stock.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Biodesix Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-25-203746), on September 15, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.